Mark Pimentel, MD, Executive Director of the Medically Associated Science and Technology Program at Cedars-Sinai, and a leading expert on microbial overgrowths, puts it this way: Any factor that slows down the speed of flow [of food] through the small intestine has the potential to cause [bacterial] overgrowth. This is important for patients assessing their SIBO risk, because studies suggest GLP-1 signaling can inhibit aspects of the Migrating Motor Complex (MMC)
It works on areas of the brain that manage our appetite and how full we feel
Patients taking a GLP-1 need to be supported by multidisciplinary care teams that practice strong patient education strategies
The result is positive feedback loops: better cellular health improves your body's ability to handle environmental stressors while reducing inflammatory responses
The addition of Cys or Hcy, however, can hardly change the hydrophobicity of TPE-DCV
27,36 In a controlled study, 63 patients with type 2 diabetes and a lower-extremity ulcer were randomized to either saxagliptin 5 mg or placebo daily
